Intra-arterial Pump Infusional Chemotherapy

  • Yasuaki Arai
Reference work entry


Intra-arterial infusion chemotherapy has a long history since 1950s, and it has been performed with surgical catheter and pump implantation. The percutaneous approach has been developed with techniques of interventional radiology since 1980s. Interventional radiology can provide minimally invasive and accurate intra-arterial infusion chemotherapy consisted of arterial redistribution, percutaneous catheter placement, and drug distribution management. With these techniques, some small studies showed promising data especially in the treatment of liver metastases, but any larger study has not been done yet. Since modern systemic chemotherapy is well advanced, the role of intra-arterial infusion chemotherapy is not much recognized in the field of medical oncology. However, intra-arterial infusion chemotherapy cannot be done without accurate knowledge and techniques. To evaluate this treatment modality correctly at the present and to decide the new role of intra-arterial infusion chemotherapy, interventional radiologists should understand their very important role on intra-arterial infusion chemotherapy.


Hepatic Artery Drug Distribution Common Hepatic Artery Indwell Catheter Infusion Chemotherapy 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Hohn DC, Stagg RJ, Friedman MA, et al. A randomized trial of continuous intravenous versus hepatic intraarterial floxuridine in patients with colorectal cancer metastatic to the liver: the Northern California Oncology Group trial. J Clin Oncol. 1989;7:1646–54.CrossRefPubMedGoogle Scholar
  2. 2.
    Kemeny N, Daly J, Reichman B, et al. Intrahepatic or systemic infusion of fluorodeoxyuridine in patients with liver metastases from colorectal carcinoma. A randomized trial. Ann Intern Med. 1987;107:459–65.CrossRefPubMedGoogle Scholar
  3. 3.
    Martin Jr JK, O’Connell MJ, Wieand HS, et al. Intra-arterial floxuridine vs systemic fluorouracil for hepatic metastases from colorectal cancer. A randomized trial. Arch Surg. 1990;125:1022–7.CrossRefPubMedGoogle Scholar
  4. 4.
    Chang AE, Schneider PD, Sugarbaker PH, et al. A prospective randomized trial of regional versus systemic continuous 5-fluorodeoxyuridine chemotherapy in the treatment of colorectal liver metastases. Ann Surg. 1987;206:685–93.CrossRefPubMedPubMedCentralGoogle Scholar
  5. 5.
    Kemeny MM, Goldberg D, Beatty JD, et al. Results of a prospective randomized trial of continuous regional chemotherapy and hepatic resection as treatment of hepatic metastases from colorectal primaries. Cancer. 1986;57:492–8.CrossRefPubMedGoogle Scholar
  6. 6.
    Rougier P, Laplanche A, Huguier M, et al. Hepatic arterial infusion of floxuridine in patients with liver metastases from colorectal carcinoma: long-term results of a prospective randomized trial. J Clin Oncol. 1992;10:1112–8.CrossRefPubMedGoogle Scholar
  7. 7.
    Allen-Mersh TG, Earlam S, Fordy C, et al. Quality of life and survival with continuous hepatic-artery floxuridine infusion for colorectal liver metastases. Lancet. 1994;344:1255–60.CrossRefPubMedGoogle Scholar
  8. 8.
    Kerr DJ, McArdle CS, Ledermann J, et al. Intrahepatic arterial versus intravenous fluorouracil and folinic acid for colorectal cancer liver metastases: a multicentre randomised trial. Lancet. 2003;361:368–73.CrossRefPubMedGoogle Scholar
  9. 9.
    Kemeny NE, Niedzwiecki D, Hollis DR, et al. Hepatic arterial infusion versus systemic therapy for hepatic metastases from colorectal cancer: a randomized trial of efficacy, quality of life, and molecular markers (CALGB 9481). J Clin Oncol. 2006;24:1395–403.CrossRefPubMedGoogle Scholar
  10. 10.
    Lorenz M, Muller HH. Randomized, multicenter trial of fluorouracil plus leucovorin administered either via hepatic arterial or intravenous infusion versus fluorodeoxyuridine administered via hepatic arterial infusion in patients with nonresectable liver metastases from colorectal carcinoma. J Clin Oncol. 2000;18:243–54.CrossRefPubMedGoogle Scholar
  11. 11.
    Allen-Mersh TG, Glover C, Fordy C, et al. Randomized trial of regional plus systemic fluorinated pyrimidine compared with systemic fluorinated pyrimidine in treatment of colorectal liver metastases. Eur J Surg Oncol. 2000;26:468–73.CrossRefPubMedGoogle Scholar
  12. 12.
    Reappraisal of hepatic arterial infusion in the treatment of nonresectable liver metastases from colorectal cancer. Meta-analysis group in cancer. J Natl Cancer Inst. 1996;88:252–8.Google Scholar
  13. 13.
    Harmantas A, Rotstein LE, Langer B. Regional versus systemic chemotherapy in the treatment of colorectal carcinoma metastatic to the liver. Is there a survival difference? Meta-analysis of the published literature. Cancer. 1996;78:1639–45.CrossRefPubMedGoogle Scholar
  14. 14.
    Mocellin S, Pilati P, Lise M, et al. Meta-analysis of hepatic arterial infusion for unresectable liver metastases from colorectal cancer: the end of an era? J Clin Oncol. 2007;25:5649–54.CrossRefPubMedGoogle Scholar
  15. 15.
    Arai Y, Inaba Y, Takeuchi Y. Interventional techniques for hepatic arterial infusion chemotherapy. In: Castaneda-Zuniga WR, Tadavarthy SM, editors. Interventional radiology. 3rd ed. Baltimore: Williams & Wilkins; 1997. p. 192–205.Google Scholar
  16. 16.
    Arai Y, Takeuchi Y, Inaba Y, et al. Percutaneous catheter placement for hepatic arterial infusion chemotherapy. Tech Vasc Interv Radiol. 2007;10:30–7.CrossRefPubMedGoogle Scholar
  17. 17.
    Collins JM. Pharmacologic rationale for regional drug delivery. J Clin Oncol. 1984;2:498–504.CrossRefPubMedGoogle Scholar
  18. 18.
    Seki H, Ozaki T, Takaki S, et al. Using slow-infusion MR arteriography and an implantable port system to assess drug distribution at hepatic arterial infusion chemotherapy. AJR Am J Roentgenol. 2003;180:681–6.CrossRefPubMedGoogle Scholar
  19. 19.
    Hirota T, Yamagami T, Tanaka O, et al. Brain infarction after percutaneous implantation of port-catheter system via the left subclavian artery. Br J Radiol. 2002;75:799–804.CrossRefPubMedGoogle Scholar
  20. 20.
    Seki H, Kimura M, Yoshimura N, et al. Hepatic arterial infusion chemotherapy using percutaneous catheter placement with an implantable port: assessment of factors affecting patency of the hepatic artery. Clin Radiol. 1999;54:221–7.CrossRefPubMedGoogle Scholar
  21. 21.
    Yamagami T, Iida S, Kato T, et al. Using n-butyl cyanoacrylate and the fixed-catheter-tip technique in percutaneous implantation of a port-catheter system in patients undergoing repeated hepatic arterial chemotherapy. AJR Am J Roentgenol. 2002;179:1611–7.CrossRefPubMedGoogle Scholar
  22. 22.
    Tanaka T, Arai Y, Inaba Y, et al. Radiologic placement of side-hole catheter with tip fixation for hepatic arterial infusion chemotherapy. J Vasc Interv Radiol. 2003;14:63–8.CrossRefPubMedGoogle Scholar
  23. 23.
    Ganeshan A, Upponi S, Hon LQ, et al. Hepatic arterial infusion of chemotherapy: the role of diagnostic and interventional radiology. Ann Oncol. 2008;19:847–51.CrossRefPubMedGoogle Scholar
  24. 24.
    Deschamps F, Elias D, Goere D, et al. Intra-arterial hepatic chemotherapy: a comparison of percutaneous versus surgical implantation of port-catheters. Cardiovasc Intervent Radiol. 2010;34(5):973–9.CrossRefPubMedGoogle Scholar
  25. 25.
    Arai Y, Inaba Y, Takeuchi Y, et al. Intermittent hepatic arterial infusion of high-dose 5FU on a weekly schedule for liver metastases from colorectal cancer. Cancer Chemother Pharmacol. 1997;40:526–30.CrossRefPubMedGoogle Scholar
  26. 26.
    Arai Y, Inaba Y, Matsueda K, et al. Weekly 5 hour hepatic arterial infusion of high dose 5FU for unresectable liver metastases from colorectal cancer in patients without extra-hepatic lesions. (ASCO 1998 abstract No. 1098). ASCO, 1998, p. 285a.Google Scholar
  27. 27.
    Arai Y, Sone Y, Tohyama N, et al. Hepatic arterial infusion for unresectable liver metastases from gastric cancer. Proc ASCO. 1992;11:176.Google Scholar
  28. 28.
    Kumada T, Arai Y, Itoh K, et al. Phase II study of combined administration of 5-fluorouracil, epirubicin and mitomycin-C by hepatic artery infusion in patients with liver metastases of gastric cancer. Oncology. 1999;57:216–23.CrossRefPubMedGoogle Scholar
  29. 29.
    Kemeny N, Jarnagin W, Paty P, et al. Phase I trial of systemic oxaliplatin combination chemotherapy with hepatic arterial infusion in patients with unresectable liver metastases from colorectal cancer. J Clin Oncol. 2005;23:4888–96.CrossRefPubMedGoogle Scholar
  30. 30.
    Ducreux M, Ychou M, Laplanche A, et al. Hepatic arterial oxaliplatin infusion puls intravenous chemotherapy in colorectal cancer with inoperable hepatic metastases: a trial of the gastrointestinal group of the Federation Nationale des Centres de Lutte Contre le Cancer. J Clin Oncol. 2005;23:4815–7.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2013

Authors and Affiliations

  1. 1.Department of Diagnostic RadiologyNational Cancer Center HospitalTokyoJapan

Personalised recommendations